[Press Release]Xenothera signs a memorandum of understanding with the Vietnamese conglomerate Vingroup

September 9,2021. # Download our press release (english version) # Télécharger notre communiqué de presse (version français).

[Press Release]Accelarated Scientific Advise from European Medicines Adgency EMA for Xav-19 Market Authorisation

July 8, 2021. # Download our press release (english version) # Télécharger notre communiqué de presse (version française)

[Newsletter] XENONEWS

Summer 2021. >> Official Xenothera newsletter /Lettre d’information officielle de Xenothera << # Download our newsletter (english version) # Télécharger notre newsletter (version française)

[Press Release] 20 M€ raised by Xenothera to accelerate its development

June 29, 2021. # Download our press release (english version) # Télécharger notre communiqué de presse (version française)

[Press Alert] XENOTHERA signs a pre-order contract of its anti-covid treatment with the French government

May 11, 2021. # Download our press information (english version) # Télécharger notre information presse (version française)

[Newsletter] XENONEWS

May 2021 >> Official Xenothera newsletter /Lettre d’information officielle de Xenothera << # Download our newsletter (english version) # Télécharger notre newsletter (version française)

[Press Alert] XENOTHERA And Its Partner Excelya Announce the Recruitment of the First Patient in The EUROXAV Clinical Trial of its COVID Treatment XAV-19

May 3, 2021. # Download our press information (english version) # Télécharger notre information presse (version française)

[Newsletter] XENONEWS

April 2021 >> Official Xenothera newsletter /Lettre d’information officielle de Xenothera << # Download our newsletter (english version) # Télécharger notre newsletter (version française)

[Press Release] Completion of patients’ enrolment in the POLYCOR clinical trial promoted by the Nantes University Hospital

April 21, 2021. # Download our press release (english version) # Télécharger notre communiqué de presse (version française)

[Press Release] Effectiveness of XAV-19 against SARS-CoV-2 variants

February 1, 2021. # Download our press release (english version) # Télécharger notre communiqué de presse (version française)